LPL and ocular melanoma: In the presence of the LpxC inhibitor PF-5081090 (PF), loss of the LPL recycling system increased growth, suppressed envelope stress responses, improved OM asymmetry, and lowered GPL levels to maintain GPL-to-LPS balance.